SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Schuermans A)
 

Sökning: WFRF:(Schuermans A) > (2023) > Clonal Hematopoiesi...

  • Gumuser, Esra D.Massachusetts General Hospital (författare)

Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease

  • Artikel/kapitelEngelska2023

Förlag, utgivningsår, omfång ...

  • 2023
  • 14 s.

Nummerbeteckningar

  • LIBRIS-ID:oai:lup.lub.lu.se:a1559a34-b8c3-4727-9466-37c08bc4c20e
  • https://lup.lub.lu.se/record/a1559a34-b8c3-4727-9466-37c08bc4c20eURI
  • https://doi.org/10.1016/j.jacc.2023.03.401DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:art swepub-publicationtype
  • Ämneskategori:ref swepub-contenttype

Anmärkningar

  • Background: Clonal hematopoiesis of indeterminate potential (CHIP)—the age-related clonal expansion of blood stem cells with leukemia-associated mutations—is a novel cardiovascular risk factor. Whether CHIP remains prognostic in individuals with established atherosclerotic cardiovascular disease (ASCVD) is less clear. Objectives: This study tested whether CHIP predicts adverse outcomes in individuals with established ASCVD. Methods: Individuals aged 40 to 70 years from the UK Biobank with established ASCVD and available whole-exome sequences were analyzed. The primary outcome was a composite of ASCVD events and all-cause mortality. Associations of any CHIP (variant allele fraction ≥2%), large CHIP clones (variant allele fraction ≥10%), and the most commonly mutated driver genes (DNMT3A, TET2, ASXL1, JAK2, PPM1D/TP53 [DNA damage repair genes], and SF3B1/SRSF2/U2AF1 [spliceosome genes]) with incident outcomes were compared using unadjusted and multivariable-adjusted Cox regression. Results: Of 13,129 individuals (median age: 63 years) included, 665 (5.1%) had CHIP. Over a median follow-up of 10.8 years, any CHIP and large CHIP at baseline were associated with adjusted HRs of 1.23 (95% CI: 1.10-1.38; P < 0.001) and 1.34 (95% CI: 1.17-1.53; P < 0.001), respectively, for the primary outcome. TET2 and spliceosome CHIP, especially large clones, were most strongly associated with adverse outcomes (large TET2 CHIP: HR: 1.89; 95% CI: 1.40-2.55; P <0.001; large spliceosome CHIP: HR: 3.02; 95% CI: 1.95-4.70; P < 0.001). Conclusions: CHIP is independently associated with adverse outcomes in individuals with established ASCVD, with especially high risks observed in TET2 and SF3B1/SRSF2/U2AF1 CHIP.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Schuermans, ArtCatholic University of Leuven,Massachusetts General Hospital,Massachusetts Institute of Technology (författare)
  • Cho, So Mi JemmaMassachusetts Institute of Technology,Massachusetts General Hospital (författare)
  • Sporn, Zachary A.Massachusetts General Hospital (författare)
  • Uddin, Md MesbahMassachusetts General Hospital,Massachusetts Institute of Technology (författare)
  • Paruchuri, KaavyaMassachusetts Institute of Technology,Massachusetts General Hospital (författare)
  • Nakao, TetsushiMassachusetts General Hospital,Brigham and Women's Hospital / Harvard Medical School,Massachusetts Institute of Technology,Dana-Farber Cancer Institute (författare)
  • Yu, ZhiMassachusetts Institute of Technology,Massachusetts General Hospital (författare)
  • Haidermota, SaraMassachusetts Institute of Technology,Massachusetts General Hospital (författare)
  • Hornsby, WhitneyMassachusetts General Hospital,Massachusetts Institute of Technology (författare)
  • Weeks, Lachelle D.Dana-Farber Cancer Institute (författare)
  • Niroula, AbhishekLund University,Lunds universitet,Hematogenomics,Forskargrupper vid Lunds universitet,Lund University Research Groups,Dana-Farber Cancer Institute,Massachusetts Institute of Technology(Swepub:lu)med-anu (författare)
  • Jaiswal, SiddharthaStanford University School of Medicine (författare)
  • Libby, PeterBrigham and Women's Hospital / Harvard Medical School (författare)
  • Ebert, Benjamin L.Dana-Farber Cancer Institute (författare)
  • Bick, Alexander G.Vanderbilt University Medical Center (författare)
  • Natarajan, PradeepMassachusetts General Hospital,Massachusetts Institute of Technology (författare)
  • Honigberg, Michael C.Massachusetts Institute of Technology,Massachusetts General Hospital (författare)
  • Massachusetts General HospitalCatholic University of Leuven (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Journal of the American College of Cardiology81:20, s. 1996-20090735-1097

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy